Delphi Venturessearch
About Us
Why Healthcare
Our Role
Our Success
Why Delphi
How We Work
Tapping The Future
Our Team
More Than Capital
Experience Counts
Our Focus
Portfolio Companies
Portfolio Companies
Representative Historical
IPO and Acquisition
News
Limited Partners
Contact Us
EXPERIENCE: Delphi Ventures is a venture capital firm that has focused on investing in medical devices and biotechnology for over two decades. With more than $1.1 billion in commited capital, Delphi Ventures has funded over 160 companies. More than 100 of our portfolio companies have either completed an initial public offering or have been acquired by a leading healthcare corporation.
ourstory
 
KAI Pharmaceuticals Aquired by Amgen
 
Cameron Health, Inc. Acquired by Boston Scientific